| CTRI Number |
CTRI/2024/05/066631 [Registered on: 01/05/2024] Trial Registered Prospectively |
| Last Modified On: |
27/04/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Ayurvedic medicine for treating Tamak shwasa (Bronchial asthama) |
|
Scientific Title of Study
|
A single arm clinical study to evaluate the efficacy of an ayurvedic formulation in the management of tamak shwasa. (Bronchial Asthma). |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Harshit Kalkhundia |
| Designation |
MD Scholar Kayachikitsa |
| Affiliation |
Dr D Y Patil college of ayurveda and research centre |
| Address |
Kayachikitsa OPD No 5.
Dr D Y Patil college of ayurveda and research centre, Sant tukaramnagar, Pimpri, Pune
Pune MAHARASHTRA 411018 India |
| Phone |
7455070127 |
| Fax |
|
| Email |
harshitkalkhundia@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr D G Dipankar |
| Designation |
M.D. Ph.D. (Kayachikitsa) |
| Affiliation |
Dr D Y Patil college of ayurveda and research centre |
| Address |
Kayachikitsa OPD No 5.
Dr D Y Patil college of ayurveda and research centre, Sant tukaramnagar, Pimpri, Pune
Pune MAHARASHTRA 411018 India |
| Phone |
9822279321 |
| Fax |
|
| Email |
digambar.dipankar@dpu.edu.in |
|
Details of Contact Person Public Query
|
| Name |
Dr D G Dipankar |
| Designation |
M.D. Ph.D. (Kayachikitsa) |
| Affiliation |
Dr D Y Patil college of ayurveda and research centre |
| Address |
Kayachikitsa OPD No 5.
Dr D Y Patil college of ayurveda and research centre, Sant tukaramnagar, Pimpri, Pune
Pune MAHARASHTRA 411018 India |
| Phone |
9822279321 |
| Fax |
|
| Email |
digambar.dipankar@dpu.edu.in |
|
|
Source of Monetary or Material Support
|
| Dr.D.Y.Patil College of Ayurveda and Research centre Sant tukaram nagar, Pimpri, Pune
Pin code-411018
Maharashtra India. |
|
|
Primary Sponsor
|
| Name |
Dr. Harshit Kalkhundia |
| Address |
Dr.D.Y.Patil College of Ayurveda and Research centre Sant tukaram nagar, Pimpri, Pune |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Harshit Kalkhundia |
Dr.D.Y.Patil College of Ayurveda and Research centre |
Kayachikitsa OPD No 5.
Dr.D.Y.Patil College of Ayurveda and Research centre Sant tukaram nagar, Pimpri, Pune 411018 Pune MAHARASHTRA |
7455070127
harshitkalkhundia@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| DR. DYPCA & RC INSTITUTIONAL ETHICS COMMITTEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:J453||Mild persistent asthma. Ayurveda Condition: TAMAKASVASAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Other than Classical | | (1) Medicine Name: Vasa, Kantakari, Bharangi, Yastimaghu, Trikatu, Sameerpannag rasa, Yava kshara, Reference: NA, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/Tablets, Dose: 1000(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 28 Days, anupAna/sahapAna: Yes(details: -Luke warm water), Additional Information: - |
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
The patient having a classical features of Tamak shwasa (Bronchial asthma) like Frequency of shwasa vega (Shortness of breath) Kasa (Cough), Pinasa (Coryza), Ghurghurukam(Wheezing) Asino labhyate soukhyam(Relieves discomfort insitting), Anidra (Disturbed sleep).
Age between 18 to 70 years.
History of Tamak shwasa less than 5 year
Peak flow meter rate more than 80lit/m and less than 300lit/m.
Class-All socio-economic classes.
|
|
| ExclusionCriteria |
| Details |
Patients with a history of Tamak Shwasa (Bronchial Asthma) more than 5 yrs.
Asthma due to other systemic disorders, and Tuberculosis Lung cancer, Cystic Fibrosis,Pneumonia, Pleural effusion, and other respiratory disorder.
Asthma in pregnant women.
Patient in status asthmaticus.
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Reduction in the symptoms of tamak shwasa(Bronchial Asthma) and improvement in the peak expiratory flow rate. |
28 days with follow up on 14th , 28th day |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To assess the improvement in peak expiratory flow rate, breath holding time, respiratory rate |
28 days with follow up on 14th , 28th day |
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "30"
Final Enrollment numbers achieved (India)="30" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
22/05/2024 |
| Date of Study Completion (India) |
01/09/2025 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
To study the efficacy of an ayurvedic formulation in management of tamak shwasa (bronchial asthama). There are total 30 patients, ayurvedic formulation of 500 mg two tablets will be given with luke warm water before food in morning and evening, the study will be of 28 days and follow up on 14th and 28th day. Peak expiratory flow rate, breath holding time, CBC with ESR, SpO2 saturation, LFT, RFT will be tested before and after and final conclusion will be drawn on the basis of statistical methods. |